Agilent Technologies is ramping up its commitment to biotechnology innovation in Asia with the expansion of its partnership with Monash University Malaysia.
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub, a state-of-the-art facility designed to accelerate regional research and development in biomedical, pharmaceutical, and molecular biology fields.
The announcement coincides with the 15-year celebration of the strategic partnership between Agilent and Monash Malaysia, marked by a newly signed MOU to advance high-impact R&D capabilities across the fast-growing Asian market.
Under the renewed agreement, Agilent will deploy its high-resolution Revident Quadrupole Time of Flight LC/MS systems, 1290 Infinity III High-Performing LC series, and next-generation 5977C Gas Chromatography/MSD at the new hub. The technologies will support joint research programs, applications development, workshops, and scientific training, enabling deeper insights in both small- and large-molecule analysis.
“This collaboration reflects Monash University Malaysia's commitment to delivering world-class research infrastructure that advances discovery and benefits our communities. The MUMPMP–Agilent BioDiscovery Hub strengthens Monash's position as a regional leader in proteomics, metabolomics, and biotechnology innovation.
"By combining Agilent's state-of-the-art technologies with Monash's research excellence and multidisciplinary ecosystem, we are empowering our scientists and partners to drive impactful solutions for Malaysia and the Asia-Pacific region,” said Syafiq Asnawi, Senior Lecturer in Biomedical Science and Director of the Department of Molecular Epidemiology & Translational Medicine and the MUM Proteomics & Metabolomics Platform.
“At Agilent, we support Monash University in enhancing biological research through proteomics, metabolomics and lipidomics. Our renewed collaboration with Monash University Malaysia continues our 15-year collaboration and positions Agilent as a leader in biotechnology innovation.
"The BioDiscovery Hub will drive scientific progress, talent development, and creating long-term value for customers and partners,” said Bharat Bhardwaj, Agilent's Vice President of Sales for Asia Pacific.
